Birgitta Jonasson, Ph.D. and Ulf Jonasson, Ph.D.
Stortorget 6
SE-641 30 Katrineholm, Sweden
Phone:
+4615010290, +46730232600
Education of Birgitta Jonasson
(BJ):
Ph.D. The Department of Forensic Medicine, Uppsala University, Sweden. 2000
Diploma in Psychotherapy, Department of Psychology, Uppsala University,
Sweden. 1983
Master of Science in psychology, Department of Psychology, Uppsala
University, Sweden. 1975
Master of Arts. Faculty of Social Sciences, Uppsala
University, Sweden. 1972
Certifications and licensing
of BJ:
Board Certified Specialist in Clinical Psychology.
1995
Certified Supervisor in psychotherapy. 1986
Licensed Psychotherapist. 1985
Licensed Psychologist. 1978
Education of Ulf Jonasson (UJ):
Dr in Public Health. The Nordic School of Public Health, NHV. 2001
B.S. Uppsala University, Sweden. 1997
College of Journalism, Stockholm, Sweden. 1988
College of Journalism, Gothenburg, Sweden. 1969-1971
Memberships and engagements of UJ:
Offices as a Local
Politician in Uppsala 2002-2005 and in Katrineholm 2005-2008, and 2011-
Member of the National
Press Club Organization since 2002 –
Member of The Swedish Union of
Journalists
Research Area for BJ and UJ
Prevalence of dependence of prescribed drugs among certain categories, such
as persons on sick leave, and in normal population.
Fatalities due to use or misuse of prescribed drugs, especially
dextropropoxyphene (DXP)
Early detection of alcohol problems and/or dependence/misuse of prescribed
drugs among patients visiting Public Health or Primary Care.
Assessment and diagnostic of dependence and misuse of alcohol/prescribed
drugs.
Professional experience of BJ:
Got retired from the National Insurance Board in 2007 and is since then
busy in the own company (Jonasson & Jonasson HB), primarily in
assignments as Senior Adviser and in giving lectures.
Employment at the National Social Insurance Board, Department
of Research, Evaluation and Statistics as a Senior Researcher in 2001.
Started a Company, Jonasson & Jonasson HB, in 1991 together with Ulf
Jonasson, with focus on Education and Research within the alcohol- and drug
area. This company is still run.
During the years 1973-2001 she ran a Private Psychologist Practice as a
Psychotherapist, Supervisor, and Head Consultant).
During the years 2006 - 2013 she worked as a supervisor for private as well as
public authorities.
Professional experience of UJ:
Freelance journalist 1971-1991.
Since 1991 he is active in the own company, Jonasson & Jonasson HB, within
the area of education, research, and journalism.
Since 2001 he has been engaged in extensive information activities and
lobbying to influence rules and regulations, when it comes to the prescription
of DXP in Sweden as well as internationally. The goal has been a complete
withdrawal of DXP from the world market.
Books and reports of BJ and/or UJ:
Jonasson U, Jonasson B.
Beroendeskapande läkemedel – ett folkhälsoproblem som ökar. Statens
Folkhälsoinstitut. Rapport nr A2006:05
Jonasson B, Jonasson U.
Restriktioner i förskrivningen av Dextropropoxifen (DXP) – effekter av försäljning
och förgiftning. Läkemedelsverkets och Rättsmedicinalverkets hemsidor (svensk
respektive engelsk version). Uppsala 2004
Jonasson U, Jonasson B. Restrictions
on the prescribing of dextropropoxyphene (DXP) – effects on sales and cases of
fatal poisoning. Report written on behalf of Rättsmedicinal-verket (National
Board of Forensic Medicine) and Läkemedelsverket (Medical Products Agency) in
co-operation with Riksförsäkringsverket (National Social Insurance Board)
and Giftinformationscentralen (Swedish Poisons Information Centre)
Jonasson B. Sjukskrivna och
vanebildande läkemedel. Användning och beroende av centralt verkande
smärtstillande, sömn- och lugnande medel bland sjukskrivna. RFV Analyserar
2003:13. Riksförsäkringsverket, Stockholm 2003.
Jonasson B, Jonasson U. Känner du
någon som dricker för mycket? Frågor och svar. SBU – Statens beredning för
medicinsk utvärdering, Apoteket AB, Stockholm 2002.
Eklund M, Jonasson B, Sundén A.
Sjukskrivnas syn på hälsa och arbete. RFV analyserar 2002:16. Riksförsäkringsverket,
Stockholm
Jonasson B. Karakteristika hos
personer som är sjukskrivna och arbetslösa. RFV redovisar 2002:1,
Riksförsäkringsverket 2002, Stockholm
Holmberg et al. Lugnande medel som
oroar. Kapitel 3, 7 och 8. Rättsmedicinalverkets rapportserie 2002:1, Fritzes,
Stockholm
Socialförsäkringsboken 2001.
Kapitlet ”Kraftfullt åldrande – tänkbara scenarier. Riksförsäkringsverket
2001, Stockholm
Jonasson B, Jonasson U. Fatalities due to use or misuse of pain-killers
containing dextropropoxyphene, RMV-rapport 2001:1
Jonasson B. Studies on dextropropoxyphene - with special reference to
dependence among chronic pain patients, classification of the manner of death
in fatal poisoning, and characteristics of the fatal poisoning victims. Dissertation
from the Faculty of Medicine. Acta Universitatis Upsaliensis, Uppsala
2000. ISBN 91-554-4729-5.
Jonasson U. Studier av bruket av
dextropropoxifen ur ett folkhälsoperspektiv. Påverkan av ett
regelverk. (Studies on the use of dextropropoxyphene from the aspect of public
health. Influende on at regulatory framework). Dissertations for the degree of
Doctor of Public Health. The Nordisc
School och Public health. Gothenburg. Sweden, 2001. ISBN 91-694798-43-2
Jonasson U och B. Dödsfall genom
bruk och missbruk av värktabletter. Rättsmedicinal-verkets rapportserie RMV- Rapport
1999:1, Fritzes, Stockholm. ISBN 91-38-31513-0.
Jonasson B and Jonasson U. Fatalities due to use or misuse of painkillers.
The Natgional Board of Forensic Medicines in Sweden . RMV-Report 2001;1. ISBN 91-38-31848-2
Jonasson B, Leo-Andersson A. Tidig
upptäckt av alkohol- och drogproblem. Brevskolans utbildningsförlag, Stockholm,
1995. Andra upplagan 1997.
Jonasson U. Droger som kan skapa
beroende. Brevskolans utbildningsförlag, Stockholm, 1995
Jonasson B, Jonasson U.
Alkoholrelaterad sjukvårdskonsumtion, tidig diagnostik och interventioner inom
primär-vård och allmän sjukvård, PM, SBU, Stockholm, 1992.
Papers and abstracts:
http://1.usa.gov/OAVwGK
Jonasson B, Saldeen T. Citalopram in fatal
poisoning cases. Forensic Sci Int 2002;28:1-6.
Jonasson B. Dextropropoxifen -
Beroende och ofrivilliga dödsfall orsakat av vanligt smärtstillande
medel. Incitament 2000;6:543–548.
Jonasson U. Dextropropoxifen – ett
skandinaviskt perspektiv. Incitament nr 7/2000;645-648.
Jonasson B. Karakteristika hos
personer som är sjukskrivna och arbetslösa. RFV redovisar
2002:1, Riksförsäkringsverket 2002, Stockholm
Jonasson U, Jonasson B, Saldeen T, Thuen F. The prevalence of analgesics
containing dextropropoxyphene or codeine in individuals suspected of driving
under influence. Forensic Sci Int2000;112:163-169.
Jonasson U, Jonasson B, Saldeen T. Middle-aged men - a risk category
regarding fatal poisoning due to dextropropoxyphene and alcohol in
combination. Prev Med 2000;31:103-6.
Jonasson B, Jonasson U, Saldeen T. Among fatal poisonings
dextropropoxyphene predominates in younger people, antidepressants in the
middle aged and sedatives in the elderly. J Forensic Sci 45 (2000) 7-10.
Jonasson U, Jonasson B, Saldeen T.
Förekomst av dextropropoxifen bland drograttfyllerister, 1992-97. Poster
vid Riksstämman för läkare, Älvsjö 1999.
Jonasson B. PM angående
klassifikation av dödssätt vid självförvållad död, med särskild betoning på
dödlig förgiftning. Rättsmedicinalverket, Stockholm, 1999.
Jonasson U, Jonasson B, Saldeen T. Correlation between prescription of
various dextropropoxyphene preparations and their involvement in fatal
poisonings. Forensic Sci Int 103 (1999) 125-132.
Jonasson B, Jonasson U, Saldeen T. Suicides may be over-reported and
accidents under-reported among fatalities due to dextropropoxyphene. J
Forensic Sci 44 (1999) 334-338.
Jonasson B, Jonasson U, Holmgren P, Saldeen T. Fatal poisoning where
ethyl-morphine from antitussive medications contributed to death. Int J
Legal Medicine 112 (1999) 299-302.
Jonasson B. Jonasson U, Saldeen T. The manner of death among fatalities
where dextropropoxyphene caused or contributed to death. Forensic Sci
Int 96 (1998) 181-187.
Jonasson U Jonasson B, Andersson E, Wickström L, T. Saldeen.Analgesic
use disorders among orthopaedic and chronic pain patients at a rehabilitation
clinic. Substance Use and Misuse 33 (1998) 1-11.
Jonasson U, Jonasson B, Holmgren P, Saldeen T. The prevalence of
dextropropoxyphene in a Swedish autopsy material. Forensic Sci. Int 96 (1998) 135-142.
Jonasson U, Jonasson B, Saldeen T.
Hög förekomst av dextropropoxifen i ett rättsmedicinskt material, Poster vidriksstämman
för läkare, Älvsjö, 1997.
Jonasson U, Jonasson B., Saldeen
T. Förekomst av alkohol, paracetamol och bensodiazepiner i ett rättsmedicinskt
material, Poster vid riksstämman för läkare, Älvsjö, 1997.
Jonasson B, Jonasson U, Ekselius L, von Knorring L. The feasibility of a
new intake routine to assess substance use disorders by means of a structured
interview. General
Hospital Psychiatry 19 (1997)
36-41.
Jonasson U, Jonasson B,
Kartläggning av alkohol- drogmissbruk hos patienter vårdade på ortopedavdelning
med diagnosinstrumentet ADDIS. Poster vid riksstämman för läkare, Älvsjö,
1994.
Jonasson B, Jonasson U. Personal
och patienter positiva till alkohol- och drogutfrågning. Poster
vid riksstämman för läkare, Älvsjö, 1994.
Participation in congresses, conventions and other professional meetings.
Dependence of prescribed drugs among persons on sick leave. A presentation
at the Public Health Conference, Stockholm, 2003. (BJ)
Research presentations at the Annual Convention of Medical Doctors in
Sweden every year during the period of 1994-2001. (BJ, UJ)
Suicides may be over-reported and accidents under-reported among fatalities due
to dextropropoxyphene. A presentation at the XIV Nordic Congress in Forensic
Medicine, Reykjavik, Iceland, 2000. (BJ)
The prevalence of fatal poisoning due to dextropropoxyphene. A
comparison between the periods 1992-96 and 1997-99. A presentation at the XIV
Nordic Congress in Forensic Medicine, Reykjavik, Iceland, 2000. (UJ)
Medical risks associated with the treatment of pain, conference convened by
the Social Board, Stockholm, 1999. Two presentations. (BJ, UJ)
Classification of the manner of death at fatal dextropropoxyphene
poisonings. Presentations at a conference arranged by the Scandinavian Pain
Medicine Association, Fredensborg, Denmark, 1998. (BJ, UJ)
The prevalence of dextropropoxyphene in autopsy blood samples. A
presentation at the XIII Nordic Congress in Forensic Medicine, Odense, Denmark,
1997. (UJ)
The implementation of a strategy for secondary alcohol prevention into Primary
Care, Conference with the theme: The Role of Religion in Substance Abuse Prevention
and Preventive education, Moscow, March 5 to 6 1996. (BJ, UJ)
Prevalence and diagnosis of analgesic dependence in pain patients,
Nordic Workshop on analgesics and addiction, Copenhagen, 1996. (BJ, UJ)
The implementation of a strategy for secondary alcohol prevention into
Primary Care, ICAA, Amsterdam, 1996. (UJ)
The implementation of a strategy for secondary prevention into Primary
Care, John F. Kennedy University, 1995. (BJ, UJ)
Outreach activities – some examples
Interviews and reportages of all kinds in social media (newspapers,
Magazines, Net News, TV, radio etc) during the years 1994-2011. Hundreds of
different publications.
Press conference at the Foreign Office, 2004. Led to publications
worldwide, e.g. in Turkey, Finland.
Initiation of Marit Paulsen, a Swedish member of the European Parliament to
raise a question considering the dangers of DXP on basis of our research. Oral
question no.10/03, the Committee on the environment, public health and consumer
policy, Brussels, 2003. (BJ, UJ). http://bit.ly/jkUVyC
Presentations of research results concerning fatal
poisoning due to dextropropoxyphene to the Swedish Parliament;
Lena Olsson (v) 1998/99:600
Yvonne Oscarsson (v) 1999/2000:355
Yvonne
Oscarsson (v) 2001/02:328
Sven-Erik
Sjöstrand (v)2002/03:So410
Cecilia Wikström (fp) ; 2004/04:385
Visit to the United States in 2003 - Washington
DC
Meeting at DEA, NIDA, Public Citizen and Senator Kennedys´s office in
Washington (UJ)
Visit to the United States in 2004 - Washington
DC
Meeting at DEA, NIDA, FDA, Public Citizen and Senator
Kennedys´s office in Washington (UJ)
Visit to the United States in 2007 - Washington
DC
Meeting with FDA and the Swedish Ambassador, Gunnar Lund
Visit to
the United States in 2012 – Washington DC
Visit to
the United States in 2013 - Washington DC
Pressrelease:
523 000 persons in the world could have been poisoned to death due to Propoxyphene during 1985 - 2011
Letter one from Public Citizen to FDA about banning
Darvon, 2006 (We are co-signers of the letter) http://bit.ly/1j0nnTh
Letter two from Public Citizen to FDA about banning
Darvon, 2009 (We are co-signers of the letter) http://bit.ly/1pMLWpq
Interviewed concerning DXP fatalities in a Russian documentary film about
the Pharmaceutical Industry. Russian National television, Channel One, November,
2010. ” Death
on prescription” Russian TV-show where we are interviewed; http://bit.ly/1oqvy0N
(We are in the program after 22 minutes)
Swedish TV during the last years:
Video on YouTube.
Some early Tweets:
We have worked
since 1993 to stop the painkiller Darvon – containing propoxyphene – in US. Now
it is done. http://bit.ly/9r5VOU
Who were
responsible for the Darvon disaster during 45 years? Of course it was Eli
Lilly. Go to http://bit.ly/exdSOn
“Darvon and
Darvocet trials will be bigger than Vioxx”, predicts Dr Ulf Jonasson – http://bit.ly/i7hnIB
Eli Lilly has
the moral responsibility for 100 000 deaths caused by Darvon since 1957. Time
to pay http://bit.ly/i7hnIB
We are just two
Davids against the Goliaths, “Big Pharma” is the enemy and we are winning the
battle.
Hundreds of trials – about the painkillers Darvon and Darvocet - will soon
start in Lexington, Kentrucky, http://bit.ly/HEMgo4
------------------------------------------------
An invitation of the Governor of the County of Södermanland to be guests at
the annual banquet dedicated to persons who in different ways have been
prominent during the last year. The Residence in Nyköping, Sweden, April, 2010.
(BJ, UJ) http://on.fb.me/lkx8mt
An invitation from the Swedish Ambassador in USA, Gunnar Lund, to present
our research. The Swedish Embassy, Washington DC, June, 2007.
(UJ) http://on.fb.me/lb87dC
An invitation to a private audience with the Swedish Queen, Her Royal
Highness Silvia, to present our work with alcohol- and drugs and to have the
honor to give her the two books we wrote in the subject in 1995. The audience
lasted for an hour. The Royal Palace, Stockholm, Sweden, 1995. (BJ, UJ) (The
Queen, who is very interested in the research field of drugs, has since then
been kept informed of the results of our research concerning dextropropoxyphene.)
Invited to the local Rotary club to inform about” David against the
Goliaths” http://bit.ly/lw098a and http://on.fb.me/jeIPvx
Updated tweets: ( May 2015)
Some of my most important tweets are about Darvon - Darvocet (DextroPropoxyphene) fatalities
